Document Detail


Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
MedLine Citation:
PMID:  21254083     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Granulocyte colony-stimulating factor (G-CSF) induces a transient mobilization of hematopoietic progenitor cells from bone marrow to peripheral blood. Our aim was to evaluate safety of repeated courses of G-CSF in patients with amyotrophic lateral sclerosis (ALS), assessing disease progression and changes in chemokine and cytokine levels in serum and cerebrospinal fluid (CSF). Twenty-four ALS patients entered an open-label, multicenter trial in which four courses of G-CSF and mannitol were administered at 3-month intervals. Levels of G-CSF were increased after treatment in the serum and CSF. Few and transitory adverse events were observed. No significant reduction of the mean monthly decrease in ALSFRS-R score and forced vital capacity was observed. A significant reduction in CSF levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-17 (IL-17) was observed. G-CSF treatment was safe and feasible in a multicenter series of ALS patients. A decrease in the CSF levels of proinflammatory cytokines MCP-1 and IL-17 was found, indicating a G-CSF-induced central anti-inflammatory response.
Authors:
Adriano Chiò; Gabriele Mora; Vincenzo La Bella; Claudia Caponnetto; Gianluigi Mancardi; Mario Sabatelli; Gabriele Siciliano; Vincenzo Silani; Massimo Corbo; Cristina Moglia; Andrea Calvo; Roberto Mutani; Sergio Rutella; Francesca Gualandi; Mario Melazzini; Rosanna Scimè; Mario Petrini; Paola Bondesan; Silvia Garbelli; Stefania Mantovani; Caterina Bendotti; Corrado Tarella;
Related Documents :
12030433 - Shift in th1 (il-2 and ifn-gamma) and th2 (il-10 and il-4) cytokine mrna balance within...
20434553 - Paclitaxel acts as an adjuvant to promote both th1 and th2 immune responses induced by ...
8408873 - Somatolactogens, somatomedins, and immunity.
Publication Detail:
Type:  Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Muscle & nerve     Volume:  43     ISSN:  1097-4598     ISO Abbreviation:  Muscle Nerve     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-21     Completed Date:  2011-02-24     Revised Date:  2011-08-03    
Medline Journal Info:
Nlm Unique ID:  7803146     Medline TA:  Muscle Nerve     Country:  United States    
Other Details:
Languages:  eng     Pagination:  189-95     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Wiley Periodicals, Inc.
Affiliation:
Dipartimento di Neuroscienze, Centro per la Sclerosi Laterale Amiotrofica, Torino, Italy. achio@usa.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amyotrophic Lateral Sclerosis / blood,  cerebrospinal fluid,  drug therapy*
Cytokines / blood,  cerebrospinal fluid
Disability Evaluation
Female
Follow-Up Studies
Granulocyte Colony-Stimulating Factor / blood,  cerebrospinal fluid,  therapeutic use*
Humans
Male
Middle Aged
Pilot Projects
Prospective Studies
Questionnaires
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cytokines; 143011-72-7/Granulocyte Colony-Stimulating Factor
Investigator
Investigator/Affiliation:
Paolo Ghiglione / ; Paola Omede / ; Marco Ulla / ; Maria Mascolo / ; Cecilia Carlesi / ; Pietro Attilio Tonali / ; Amelia Conte / ; Marco Luigetti / ; Dario Alimonti / ; Francesco Onida / ; Patrizia Bossolasco / ; Giorgio Lambertenghi Deliliers / ; Francesca Valentino /
Comments/Corrections
Comment In:
Muscle Nerve. 2011 Jul;44(1):149; author reply 149-50   [PMID:  21674531 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pediatric sciatic neuropathy associated with neoplasms.
Next Document:  The somatosensory blink reflex in upper and lower brainstem lesions.